OPKO Health Announces Closing of Private Offering of 230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchasers Option to Purchase Additional Notes
| OPK Stock | USD 1.47 0.03 2.00% |
About 62% of Opko Health's investor base is looking to short. The analysis of the overall investor sentiment regarding Opko Health suggests that many traders are alarmed. Opko Health's investing sentiment shows overall attitude of investors towards Opko Health.
Opko |
MIAMI, Jan. 09, 2024 -- OPKO Health, Inc. today announced the closing of its previously announced private offering of 230.0 million aggregate principal amount of its Convertible Senior Notes due 2029 , which amount includes the full exercise of the initial purchasers option to purchase an additional 30.0 million aggregate principal amount of the Notes. The Notes are senior unsecured obligations of the Company, bear interest at a rate
Read at finance.yahoo.com
 |
Opko Health Fundamental Analysis
We analyze Opko Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Opko Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Opko Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Opko Health is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Opko Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Opko Health stock to make a market-neutral strategy. Peer analysis of Opko Health could also be used in its relative valuation, which is a method of valuing Opko Health by comparing valuation metrics with similar companies.
Peers
Opko Health Related Equities
| TTOO | T2 Biosystms | 8.70 | ||||
| GH | Guardant Health | 4.59 | ||||
| TWST | Twist Bioscience | 1.83 | ||||
| CDNA | Caredx | 1.03 | ||||
| IDXX | IDEXX Laboratories | 0.41 | ||||
| NTRA | Natera | 0.06 | ||||
| A | Agilent Technologies | 0.1 | ||||
| ME | 23Andme Holding | 0.28 | ||||
| CSTL | Castle Biosciences | 0.45 | ||||
| FLGT | Fulgent Genetics | 3.80 | ||||
| ILMN | Illumina | 3.99 | ||||
| BDSX | Biodesix | 10.00 |
Check out Opko Health Hype Analysis, Opko Health Correlation and Opko Health Performance. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.